China Resources Pharmaceutical logo

3320 - China Resources Pharmaceutical Share Price

HK$7.2 0.1  0.7%

Last Trade - 7:53am

Sector
Healthcare
Size
Large Cap
Market Cap £4.36bn
Enterprise Value £8.79bn
Revenue £19.21bn
Position in Universe 264th / 5951
Bullish
Bearish
Unlock 3320 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

3320 Revenue Unlock 3320 Revenue

Net Income

3320 Net Income Unlock 3320 Revenue

Normalised EPS

3320 Normalised EPS Unlock 3320 Revenue

PE Ratio Range

3320 PE Ratio Range Unlock 3320 Revenue

Dividend Yield Range

3320 Dividend Yield Range Unlock 3320 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
3320 EPS Forecasts Unlock 3320 Revenue
Profile Summary

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated May 10, 2007
Public Since October 28, 2016
No. of Shareholders: n/a
No. of Employees: 66,000
Sector Healthcare
Industry Pharmaceuticals
Index Hang Seng Composite , Hang Seng Composite LargeCap & MidCap , Hang Seng Mainland 100 ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 6,284,506,461
Free Float (0.0%)
Eligible for
ISAs
SIPPs
3320 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 3320
Upcoming Events for 3320
Thursday 19th March, 2020 Estimate
Full Year 2019 China Resources Pharmaceutical Group Ltd Earnings Release
Wednesday 27th May, 2020 Estimate
China Resources Pharmaceutical Group Ltd Annual Shareholders Meeting
Similar to 3320
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.